Review
doi: 10.1016/s0025-7125(16)30763-5.
Topical and systemic antifungal agents
Affiliations
- PMID: 3280911
- DOI: 10.1016/s0025-7125(16)30763-5
Item in Clipboard
Review
Topical and systemic antifungal agents
Med Clin North Am.
1988 May.
Abstract
Superficial fungal infections are frequent and can cause considerable morbidity. Many topical agents are available that are effective against most of these infections. Systemic fungal infections are increasing in frequency, especially among immunocompromised hosts. Amphotericin B remains the most important therapeutic agents but is associated with significant acute and chronic toxicities.
Similar articles
-
Treatment of systemic fungal infections: recent progress and current problems.Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):460-75. doi: 10.1007/BF01962595. Eur J Clin Microbiol Infect Dis. 1988. PMID: 2846299 Review.
-
Effective systemic antifungal agents.Am Fam Physician. 1984 Dec;30(6):162-7. Am Fam Physician. 1984. PMID: 6095631 No abstract available.
-
Drugs for treatment of systemic fungal infections.Med Lett Drugs Ther. 1984 Mar 30;26(658):36-8. Med Lett Drugs Ther. 1984. PMID: 6321929 No abstract available.
-
Systemic antifungal drugs.Med Lett Drugs Ther. 1996 Feb 2;38(967):10-2. Med Lett Drugs Ther. 1996. PMID: 8559113 No abstract available.
-
Recent advances in the treatment of systemic fungal infections.Methods Find Exp Clin Pharmacol. 1987 Nov;9(11):769-78. Methods Find Exp Clin Pharmacol. 1987. PMID: 2834615 Review.
Cited by
-
Emerging fungal pathogens.Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):323-30. doi: 10.1007/BF01963467. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2497012 Review.
-
Adverse drug reactions to systemic antifungals. Prevention and management.Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003. Drug Saf. 1992. PMID: 1418692 Review.
-
Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.Mycopathologia. 1992 Dec;120(3):133-8. doi: 10.1007/BF00436389. Mycopathologia. 1992. PMID: 1494357
-
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.Pharmacoeconomics. 1998 May;13(5 Pt 1):509-18. doi: 10.2165/00019053-199813050-00004. Pharmacoeconomics. 1998. PMID: 10180750 Clinical Trial.
-
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665-8. doi: 10.1007/BF01975823. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1748123
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
